Skip to content

SmokefreeMOM: Reaching Pregnant Smokers With Health Information Via Text Messaging

Quit4Baby: Reaching Pregnant Smokers With Health Information Via Text

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02412956
Acronym
SmokefreeMOM
Enrollment
99
Registered
2015-04-09
Start date
2013-01-31
Completion date
2016-08-31
Last updated
2021-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Smoking Cessation

Keywords

mHealth

Brief summary

Despite the great health benefits associated with smoking cessation in pregnancy to both mother and baby, few studies to date have examined the applications of text messaging or other communication technologies for smoking cessation in this population. This project is the first step in developing a new dissemination strategy for reaching pregnant smokers. This research will explore how a state-of -the-art, interactive and intensive, text messaging program, SmokefreeMoms Text, can promote smoking cessation in pregnant smokers. This program may have the potential to reach pregnant smokers who are not currently being reached with traditional smoking cessation services. The study Aims are: 1) to elicit qualitative feedback from pregnant smokers and recent quitters (in the past month) about the concept of SmokefreeMoms, the proposed message protocols in SmokefreeMoms, and the proposed messages in SmokefreeMoms (Phase 1); 2) To develop and pilot test a prototype of SmokefreeMoms which is consistent with Clinical Practice Guidelines (Phase 2), and 3) To conduct a formative evaluation of SmokefreeMoms 1.0 with pregnant smokers and recent quitters (Phase 3). 4) To measure the likelihood that pregnant women who smoke cigarettes will join an SMS program by responding to different types of recruitment messages.

Interventions

BEHAVIORALSmokefreeMOM Text

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

1. pregnant, 2. smoke or quit in the past 2 weeks, 3. has a data plan or an unlimited text messaging plan on her cell in order to avoid charges for texts, 4. an English speaker.

Exclusion criteria

1. not pregnant 2. not currently smoking (or within past 2 weeks) 3. not able to receive text messages 4. not an English speaker

Design outcomes

Primary

MeasureTime frameDescription
Smoking Abstinence3 months7-day point prevalence abstinence measured by Self-Report and Confirmed with Saliva Cotinine

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from 11 obstetrics-gynecology clinics from 9/5/14 to 5/25/16; 9 from Medstar Health, one GWU MFA, and the other Capital Women's Care. The recruitment occurred via the electronic medical record as smokers and pregnant and sent a letter about the study. Subjects were recruited by physicians at the time of visit and were called by study staff.

Participants by arm

ArmCount
Control
Pamphlet
44
Intervention
SmokefreeMOM text messaging program and SmokefreeMOM text messaging program+ Quitline
55
Total99

Baseline characteristics

CharacteristicTotalControlIntervention
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
99 Participants44 Participants55 Participants
Age, Continuous27.66 years
STANDARD_DEVIATION 4.9
28.25 years
STANDARD_DEVIATION 4.78
27.18 years
STANDARD_DEVIATION 4.98
Region of Enrollment
United States
99 participants44 participants55 participants
Sex: Female, Male
Female
99 Participants44 Participants55 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 55
other
Total, other adverse events
0 / 440 / 55
serious
Total, serious adverse events
0 / 440 / 55

Outcome results

Primary

Smoking Abstinence

7-day point prevalence abstinence measured by Self-Report and Confirmed with Saliva Cotinine

Time frame: 3 months

ArmMeasureValue (NUMBER)
ControlSmoking Abstinence4 participants
InterventionSmoking Abstinence8 participants

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026